Key facts
- This page summarizes Moshe Citronowicz's Form 4 filing for Apyx Medical Corp (APYX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 15 Jun 2026, 19:00.
Moshe Citronowicz - 11 Jun 2026 Form 4 Insider Report for Apyx Medical Corp (APYX)
- Reporting relationship
- Sr. V.P. of Operations
- Issuer ticker
- APYX
- Reported as of
- 11 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Jun 2026, 19:00:02 UTC
- Prior SEC filing
- 17 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Moshe Citronowicz
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Moshe Citronowicz filed Form 4 for Apyx Medical Corp (APYX) on 15 Jun 2026.
Change
- Previous filing in this sequence was filed on 17 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001280851
Primary reporting owner
CITRONOWICZ MOSHE
- Relationship
- Sr. V.P. of Operations
- Address
- C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER
- Signature
- /s/ Moshe Citronowicz
- Signature date
- 15 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
APYX
transaction
Derivative
Stock Option (Option to Buy)
Award
- Transaction value
- Shares
- +63,392
- Change %
- Price
- $0.000000*
- Shares after
- 63,392
- Date
- 11 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 63,392
- Exercise price
- $4.65
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.